References
Bankowitz RA, McNeil MA, Challinor SM, Parker RC, Kapoor WM, et al. A computer-assisted medical diagnostic consultation service. Annals of Internal Medicine 110: 824–832, 1989
Bleich HL. Computer-based consultation: electrolyte and acid-base disorders. American Journal of Medicine 53: 285–291, 1972
Davis R, Buchanan B, Shortliffe E. Production rules as a representation for a knowledge-based consultation program. Artificial Intelligence 8: 15–45, 1977
de Dombal F. Computer-aided diagnosis of acute abdominal pain. British Medical Journal 2: 9–13, 1972
de Dombal F. Computer-aided decision suppport in clinical medicine. International Journal of Biomedical Computers 24: 9–16, 1989
Ghajar BM, Naranjo CA, Shear NH, Lanctôt KL. Improving the accuracy of the differential diagnosis of idiosyncratic adverse drug reactions (IADRs): skin eruptions and sulfonamides. Clinical Pharmacology and Therapeutics 47: 127, 1990
Hutchinson TA, Dawid AP, Spiegelhalter DJ, Cowell RG, Roden S. Computerized aids for probabilistic assessment of drug safety. I: a spreadsheet program. Drug Information Journal 25: 29–39, 1991a
Hutchinson TA, Dawid AP, Spiegelhalter DJ, Cowell RG, Roden S. Computerized aids for probabilistic assessment of drug safety. II: an expert system. Drug Information Journal 25: 41–48, 1991b
Kahneman D, Slovic P, Tversky A. Judgement under uncertainty: heuristics and biases, Cambridge University Press, Cambridge, 1982
Koch-Weser J, Sellers E, Zacest R. The ambiguity of adverse drug reactions. European Journal of Clinical Pharmacology 11: 75–86, 1977
Kramer MS, Levanthal JM, Hutchinson TA, Feinstein TR. An algorithm for the operational assessment of adverse drug reactions: I. Background description and instructions for use. Journal of the American Medical Association 242: 623–632, 1979
Lanctôt KL, Naranjo CA. Using microcomputers to simplify the Bayesian causality assessment of adverse drug reactions. Pharmaceutical Medicine 4: 185–195, 1990
Lanctôt KL, Naranjo CA. Computer-assisted evaluation of adverse drug events. Journal of Clinical Pharmacology, in press, 1991
Lane DA, Kramer MS, Hutchinson TA, Jones JK, Naranjo CA. The causality assessment of adverse drug reactions using a Bayesian approach. Pharmaceutical Medicine 2: 265–283, 1987
Mabry ME, Miller RA. Distinguishing drug toxicity syndromes from medical diseases: a QMR computer-based approach. Proceedings of the symposium on Computer Applications in Medical Care, IEEE. pp. 65–71, Computer Society Press, 1990
Miller RA, McNeil MA, Challinor SM, Masarie Jr FE, Myers JD. The Internist 1/Quick Medical Reference project-status report. Western Medical Journal 145: 816–822, 1986
Miller RA, Schaffner KF, Meisel A. Ethical and legal issues related to the use of computer programs in clinical medicine. Annals of Internal Medicine 102: 529–536, 1985
Naranjo CA. A clinical pharmacological perspective on the detection and assessment of adverse drug reactions. Drug Information Journal 20: 387–393, 1986
Naranjo CA, Busto U, Sellers EM, Spino M, Sandor P, et al. A reliable method for estimating the probability of adverse drug reactions. Clinical Pharmacology and Therapeutics 30: 239–245, 1981
Naranjo CA, Lanctôt KL, Lane DA. The Bayesian differential diagnosis of neutropenia associated with antiarrhythmic agents. Journal of Clinical Pharmacology 30: 1120–1127, 1990a
Naranjo CA, Lanctôt KL. Microcomputer-assisted Bayesian differential diagnosis of severe adverse reactions to new drugs: a 4-year experience. Drug Information Journal 25: 243–250, 1991a
Naranjo CA, Lanctôt KL. Towards the development of international standards for the differential diagnosis of adverse drug events. In Ruiz Ferrán et al. (Eds) Communication in pharmaceutical medicine: a challenge for 1992, pp. 175–181, J.R. Prous, S.A., Barcelona, 1991b
Naranjo CA, Lane D, Ho-Asjoe M, Lanctôt KL. A Bayesian assessment of idiosyncratic adverse reactions to new drugs: Guillain-Barré syndrome and zimeldine. Journal of Clinical Pharmacology 30: 174–180, 1990b
Reggia JA, Tuhrim S. Methods for computer-assisted medical decision making. In Reggia & Tuhrim (Eds) Computer-assisted medical decision making, Vol 1, pp. 3–45, Springer-Verlag, New York, 1985
Shear NH. Diagnosing cutaneous adverse reactions to drugs. Archives of Dermatology 126: 94–97, 1990
Shortliffe EH. Computer programs to support clinical decision making. Journal of the American Medical Association 258: 61–66, 1987
Spiegelhalter DJ. Computers, expert systems, and ADRs: can causality assessment be automated? Drug Information Journal 20: 543–550, 1986
Spielberg SP, Gordon GB, Blake DA, Goldstein DA, Herlong HF. Predisposition to phenytoin hepatoxicity assessed in vitro. New England Journal of Medicine 305: 722–727, 1981
Stephens MDB. The diagnosis of adverse medical events associated with drug treatment. Adverse Drug Reactions and Acute Poisoning Reviews 6: 1–35, 1987
Sutton GC. Computer-aided diagnosis: a review. British Journal of Surgery 76: 82–85, 1989
Szolovits P, Patil RS, Schwartz WB. Artificial intelligence in medical diagnosis. Annals of Internal Medicine 108: 80–87, 1988
Teach RL, Shortliffe EH. An analysis of physician attitudes regarding computer-based clinical consultation systems. Computers and Biomedical Research 14: 542–558, 1981
Van Way CW, Murphy JR, Dunn EL, Elerding SC. A feasibility study of computer aided diagnosis in appendicitis. Surgery, Gynecology and Obstetrics 155: 685–688, 1982
Waxman HS, Worley WE. Computer-assisted adult medical diagnosis: subject review and evaluation of a new microcomputer-based system. Medicine 69: 125–136, 1990
Author information
Authors and Affiliations
Additional information
The views expressed are those of the authors and do not necessarily reflect the views of the Addiction Research Foundation.
Rights and permissions
About this article
Cite this article
Naranjo, C.A., Lanctôt, K.L. Recent Developments in Computer-Assisted Diagnosis of Putative Adverse Drug Reactions. Drug-Safety 6, 315–322 (1991). https://doi.org/10.2165/00002018-199106050-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199106050-00001